Immunoprecise Antibodies Ltd (IPA)

6.580
+0.270(+4.28%)
After Hours
6.460
-0.120(-1.824%)
- Delayed Data
  • Volume:
    68,095
  • Bid/Ask:
    6.140/6.780
  • Day's Range:
    6.350 - 6.720

IPA Overview

Prev. Close
6.31
Day's Range
6.35-6.72
Revenue
14.84M
Open
6.41
52 wk Range
5.05-33.34
EPS
-
Volume
68,095
Market Cap
128.1M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
2,308,000
P/E Ratio
-
Beta
-
1-Year Change
-23.93%
Shares Outstanding
19,347,190
Next Earnings Date
-
What is your sentiment on Immunoprecise Antibodies Ltd?
or
Market is currently closed. Voting is open during market hours.

Immunoprecise Antibodies Ltd News

Immunoprecise Antibodies Ltd Analysis

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesBuyBuyStrong BuyNeutralBuy
Technical IndicatorsBuyStrong BuyStrong BuyBuySell
SummaryBuyStrong BuyStrong BuyNeutralNeutral

Immunoprecise Antibodies Ltd Company Profile

Immunoprecise Antibodies Ltd Company Profile

Employees
73
Market
Canada

ImmunoPrecise Antibodies Ltd., together with its subsidiaries, engages in antibody production and related services in the United States, Canada, Europe, and internationally. The company offers a range of antibodies, enzymes, enzyme activity assays, arthritis animal products, proteins, deiminated proteins, organoid growth factors, and hybridoma products for research purposes. Its services include custom antigen modeling, design, and manufacturing; B cell sorting, screening, and sequencing; custom, immune, and naive phage display production and screening; transgenic animals and multi-species antibody discovery; bi-specific, tri-specific, VHH, and VNAR (shark) antibody manufacturing; DNA cloning, protein and antibody downstream processing; antibody characterization on label-free biosensors and antibody engineering; transient and stable cell line generation; antibody optimization and humanization; hybridoma production with multiplexed, high-throughput screening, and clone-picking; and cryopreservation. The company has a research collaboration agreement with Pierre Fabre S.A for antibody discovery. ImmunoPrecise Antibodies Ltd. was incorporated in 1983 and is based in Victoria, Canada.

Read More
  • Moment of truth 8,25
    0
    • does anyone think this will have another run up like it did on July 22
      0
      • Back in 14,27CDN
        0
        • Out 17,14
          0
      • Finally … IPA getting the love it deserves 🚀
        0
        • In @ 11,70
          0
          • Ooof
            0
          • Looks better now:)
            0
          • Out 17,50CDN
            0
        • great for weekly /monthly
          0
          • what's the deal here? is it going down again?
            0
            • Great buy right now 1 month MA going bullish
              1
              • Thinking of buying now 🧐, not sure
                0
            Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
            Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.